Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study Evaluating Rocatinlimab in Moderate-to-severe Atopic Dermatitis (ROCKET-IGNITE)

ClinicalTrials.gov ID: NCT05398445

Public ClinicalTrials.gov record NCT05398445. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 16, 2026, 8:49 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, 24-week, Randomized, Placebo-controlled, Double-blind Study to Assess the Efficacy, Safety and Tolerability of Rocatinlimab (AMG 451) Monotherapy in Adult Subjects With Moderate-to-severe Atopic Dermatitis (AD)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the efficacy and safety of rocatinlimab in monotherapy treatment.

Study identification

NCT ID
NCT05398445
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Amgen
Industry
Enrollment
769 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 100 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2022 (Actual)
Primary completion
Nov 28, 2024 (Actual)
Completion
Jan 13, 2025 (Actual)
Last update posted
Jul 23, 2026

2022 – 2025

United States locations

U.S. sites
50
U.S. states
25
U.S. cities
47
Facility City State ZIP Site status
Cahaba Dermatology and Skin Health Center Birmingham Alabama 35244 —
Alliance Dermatology and Mohs Center Phoenix Arizona 85032 —
Anaheim Clinical Trials Anaheim California 92801 —
First OC Dermatology Fountain Valley California 92708 —
Kaiser Permanente - Glendale Medical Center Glendale California 91203 —
Long Beach Research Institute Long Beach California 90805 —
Kaiser Permanente Los Angeles Medical Center Los Angeles California 90027 —
Dermatology Research Associates Los Angeles California 90045 —
Cura Clinical Research Sherman Oaks California 91403 —
IMMUNOe Research Centers Centennial Colorado 80112 —
Skin Care Research Incorporated Boca Raton Florida 33486 —
Palm Beach Dermatology Group Delray Beach Florida 33484 —
Global Research Associates Homestead Florida 33030 —
Healthy Life Research Miami Florida 33175 —
Savin Medical Group LLC Miami Lakes Florida 33014 —
Kirsch Dermatology LLC Naples Florida 34102 —
Pure Skin Dermatology and Aesthetics Orlando Florida 32819 —
Industrial Medicine Associates Ima Clinical Research Inc St. Petersburg Florida 33709 —
Genesis Clinical Research LLC Tampa Florida 33606 —
Treasure Valley Medical Research Boise Idaho 83706 —
DeNova Research Chicago Illinois 60611 —
Dundee Dermatology West Dundee Illinois 60118 —
The Indiana Clinical Trials Center PC Plainfield Indiana 46168 —
Institute for Asthma and Allergy Chevy Chase Maryland 20815 —
Continental Clinical Solutions, LLC Towson Maryland 21204 —
Henry Ford Health System Detroit Michigan 48202 —
Onyx Clinical Research Flint Michigan 48532 —
Dermatology and Skin Cancer Center of Lees Summit Lee's Summit Missouri 64064 —
Jubilee Clinical Research Inc Las Vegas Nevada 89106 —
Allcutis Research, Llc - Portsmouth Portsmouth New Hampshire 03801 —
Continental Clinical Solutions - Cherry Hill Cherry Hill New Jersey 08034 —
Industrial Medicine Associates Ima Clinical Research Inc Hartsdale New York 10530 —
Sadick Research Group New York New York 10075 —
Dermatology Specialists of Charlotte Charlotte North Carolina 28277 —
Onsite Clinical Solutions Charlotte North Carolina 28277 —
Wilmington Dermatology Center Wilmington North Carolina 28405 —
The Skin Surgery Center for Clinical Research Winston-Salem North Carolina 27103 —
Optima Research Boardman Ohio 44512 —
ClinOhio Research Services Columbus Ohio 43213 —
Unity Clinical Research Oklahoma City Oklahoma 73118 —
Dermatology Research Center of Oklahoma, PLLC Tulsa Oklahoma 74132 —
Essential Medical Research LLC Tulsa Oklahoma 74137 —
Oregon Health and Science University Portland Oregon 97239 —
DermDox Dermatology, LLC Sugarloaf Pennsylvania 18249 —
Cumberland Skin Center Hermitage Tennessee 37076 —
Dermatology Treatment and Research Center PA Dallas Texas 75230 —
The Woodlands Dermatology Associates The Woodlands Texas 77380 —
Education and Research Foundation Inc Lynchburg Virginia 24501 —
Frontier Derm Partners Mill Creek Washington 98012 —
West Virginia Research Institute Morgantown West Virginia 26505 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 152 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05398445, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 23, 2026 · Synced Oct 16, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05398445 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →